President Donald Trump walks past HHS secretary Alex Azar (Saul Loeb/AFP via Getty Images)
October 6, 2020 07:58 AM EDTUpdated 03:17 PM
FDA+
Coronavirus

Trump of­fi­cials said in­dus­try did­n't want FDA's stricter vac­cine guid­ance, but the lead­ing de­vel­op­er says they nev­er dis­cussed it

Arsalan Arif

Founder

Jason Mast

Editor

There are four weeks to the elec­tion. Se­nior Trump of­fi­cials are now cit­ing in­dus­try op­po­si­tion as the rea­son they are block­ing the FDA from mak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times